Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > People expecting more bad news post

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Feb 15, 2023 1:18pm

104 Views

Post# 35287842

People expecting more bad news post

Even if I feel cheated out of my retirement money, at some point when a stock is 90% down and that they're not bankrupted one has to wonder how long can such misery can last. Hopefully not for ever and the actual market is pricing bankrupcy in the next 36 months. Don't think so even if I lost all confidence in the management and the BOD.

<< Previous

Bullboard Posts

Next >>

Mining companies take action on reconciliation with First Nations